TheStreet’s Action Alerts PLUS Portfolio Manager Jim Cramer bullish on Abbott Laboratories’ acquisition of St. Jude Medical . ‘What CEO Miles White is doing is taking advantage of the fact that St. Jude doesn’t have the scale – St. Jude has fabulous devices for the heart, but they don’t have the scale to compete against Medtronic ,’ Cramer said.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
